After months of deliberation and a final back and forth between the Canadian Senate and Parliament, Bill C-45, also known as the cannabis act, was approved on Tuesday (June 19) night.

It will become the law of the land starting on October 17, Canadian Prime Minister Justin Trudeau announced on Wednesday (June 20).


During question period on Wednesday, Trudeau declared the date, saying the provinces asked for more time on the implementation of the bill. Later, Health Minister Ginette Petitpas Taylor tweeted and confirmed the October date.

“[The provinces and territories] needed more time to transition into this framework,” Trudeau said during a remark at the end of the Parliamentary session.

After the Senate received the bill back from the House, with a clear rejection to a majority of the Senators’ proposed amendments, the historic vote was determined with a 52-to-29 win with two abstentions. This decision will open the gates to an estimated multibillion-dollar industry in Canada.

“With the Cannabis Act, the business environment in Canada is expected to move toward cooperation with the support of federal, provincial and local government,” said Kenneth Sam, partner at law firm Dorsey & Whitney and a member of the firm’s Canada cross-border practise group.

He added, “[a]n entire industry is developing and there are ground floor opportunities for businesses and governments to emerge as leaders in the industry.”

Restrictions still present despite bill approval

Even though Bill C-45’s approval indicates marijuana will officially be legal in Canada, Justice Minister Jody Wilson-Raybould said on Tuesday that current restrictions still apply and will do so until the government’s picked date of implementation in October.

In February, the health minister said that once the bill obtained royal assent, it would take the government eight to 12 weeks in order to actually kick off sales of recreational cannabis.

The government indicated in a statement that Health Canada will publish “final regulations” for the cannabis act and will expand public outreach meant to educate consumers on the limitations of the bill related to consumption and possession of the drug.

Before Canada passed its bill, only Uruguay had been able to completely legalize the drug through a sweeping national policy. In the US, nine states have legalized recreational use of the drug, while 29 states have made medical use legal.

Thanks to pending royal assent for the bill, Trudeau and the Liberals are able to deliver on a key campaign promise for their government.

Despite the legalization of the drug, many restrictions will remain in place for its consumption. Edibles and other infused products will remain banned for the first year of recreational sales. That’s a decision advocates have said will cause consumers to continue selecting products on the black market.

“There will be strict limits on advertising marijuana, and it will likely be sold in uniform packages that carry health warnings as their only decoration,” the New York Times reported.

Provinces have been allowed to select how consumers will obtain cannabis through retail methods. In Ontario, a government-run chain of stores is set to open this year, while in Manitoba privately run stores will be made available to consumers. BC has announced it will run its own stores while also allowing some form of retail presence from the private sector.

Bill passed, public market runup incoming?

Jason Zandberg, an analyst covering the cannabis space for PI Financial, told the Investing News Network (INN) he expects retail winners in the public market to provide a boom for the sector.

“I expect [rallies to happen] when we see some licensing on the retail side, those winners that were awarded licenses,” he said.

In May, INN also asked Russell Stanley, cannabis analyst with Echelon Wealth, his opinion on whether the public sector will see a runup after the setting of the date of legalization.

“There is the potential for these stocks — to or for sentiment — to improve once the doors are open and people come to understand how much product is in demand,” Stanley said.

US Election 2020 and Cannabis

 
Investing in cannabis? Read what experts have to say about cannabis and the US Election!
 

When it comes to which particular announcements will have a significant impact on the market, Stanley told INN he sees more M&A activity and the entrance of “strategic investors” as the key potential drivers.

Initial market reaction to cannabis act approval

In Wednesday’s trading session, cannabis stocks and public exchange-traded funds (ETFs) traded upward in a moderated fashion.

At market closure, the Horizons Marijuana Life Sciences Index ETF (TSX:HMMJ) had increased 3.43 percent in value, reaching a price of C$19.60. Additionally, the Evolve Marijuana ETF (TSX:SEED) went up 4.23 percent and finished the day at a value of C$18.

The Canadian Marijuana Index opened on Wednesday with a 20-point increase to begin tracking at a value of 655.63 points. After the public markets closed, the index finished with a value of 654.14 points, a 4.24-percent increase from its previous close.

This index tracks 24 public cannabis companies across the Toronto Stock Exchange, TSX Venture Exchange and Canadian Securities Exchange.

Close to the end of trading, some of the index’s top-gaining Canadian stocks included Hiku Brands (CSE:HIKU), Auxley Cannabis Group (TSXV:XLY), WeedMD (TSX:WMD) and Cronos Group (TSX:CRON).

The index also indicated on Wednesday that some of the most active stocks included Canadian licensed producers such as Aurora Cannabis (TSX:ACB), Canopy Growth (TSX:WEED) and Aphria (TSX:APH).

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: Hiku Brands is a client of the Investing News Network. This article is not paid-for content.

US Election 2020 and Cannabis

 
Investing in cannabis? Read what experts have to say about cannabis and the US Election!
 

/NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES /

  4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) (” 4Front ” or the ” Company “) is pleased to announce that it has completed its previously announced bought deal prospectus offering (the ” Offering “) of units of the Company (” Units “), for aggregate gross proceeds of C$17,251,150 including full exercise of the over-allotment option granted to the underwriters in connection therewith.

Keep reading... Show less

Khiron Life Sciences Corp. (“ Khiron ” or, the “ Company ”) (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), announced today that it has re-filed its unaudited condensed interim consolidated financial statements, together with the notes thereto, for the three and six months ended June 30, 2020 and 2019 (the “ Interim Financial Statements ”) to correct, among other things, certain 2019 comparative period information and to update certain presentation arising from the Company’s early adoption of IFRS 3 in late 2019, which changes were identified in connection with the Company’s review engagement with its auditor. The Company does not consider these adjustments either individually nor in the aggregate, to be material.

The re-filed Interim Financial Statements reflect changes to the Condensed Interim Consolidated Statements of Loss and Comprehensive Loss comparative period to remove transaction fees from the income statement and capitalize them to the applicable acquisition in accordance with the Company’s early adoption of the amended IFRS 3 as set out in Note 2, and to reclassify $1 million from general and administrative expenses to transaction fees for presentation purposes to conform with the Company’s presentation used in its audited consolidated financial statements for the years ended December 31, 2019 and 2018 (the “ Audited Annual Financial Statements ”). The re-filed interim Financial Statements also reflect changes to the Condensed Interim Consolidated Statement of Changes in Shareholders’ Equity to correct the 2019 comparative period balances as they incorrectly reflect Q1 2019 period balances, update certain presentation to conform with the Company’s presentation used in its Audited Annual Financial Statements; and reduce the valuation conclusion of the Company’s acquisition of NettaGrowth International Inc. to conform with the Audited Annual Financial Statements. The re-filed Interim Financial Statements also bring forward the subsequent event note disclosure.

Keep reading... Show less

Part of “Rooted in Good” CSR Platform, “Feed the Block” Gives Back Through Strategic Social Partnerships with Local Organizations Focused on Food Insecurity

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading U.S. provider of consumer products in cannabis, today announced a multi-state fundraising initiative in which proceeds will benefit 24 locally run food banks, homeless shelters and nonprofits working to proactively address the needs of those facing food insecurity in communities across America. This effort is a part of the Strategic Social Partnerships pillar within Curaleaf’s “Rooted in Good” Corporate Social Responsibility platform.

Keep reading... Show less

On September 8, 2020, Aurora Cannabis Inc. (NYSE:ACB) stunned the market when it announced that it expected to record up to $1.8 billion in goodwill impairment charges in the fourth quarter of 2020. On the same day, Aurora also announced a charge of approximately $140 million in the carrying value of certain inventory, and that it was appointing a new chief executive officer. On this news, Aurora’s stock fell approximately 11.6% in just one day. Since May 2020, Aurora’s stock is down approximately $10.00 per share

A lawsuit alleging violations of federal securities laws has been filed against Aurora and certain of its officers and directors. The suit alleges, among other things, that Aurora misled investors as to the value of prior acquisitions, that the Company had experienced degradation in certain assets, and that as a result, it was foreseeable that Aurora would record significant goodwill and asset impairment charges. According to the lawsuit, this news was so shocking because Aurora had previously lauded a “business transformation plan” that would purportedly “better align the business financially with the current realities of the cannabis market.”

Keep reading... Show less

  • Exclusive patent licensed from University of Idaho.
  • Mustard-derived fumigation of stored food – targeting vegetables and potatoes.
  • Leading agrochemical for sprout suppression – chlorpropham – banned by European Union on Oct. 8, 2020.
  • Appointment of Scientific Advisor Dr. Matthew J. Morra, professor emeritus of soil biochemistry at University of Idaho.

 MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the “Company”, “MustGrow”) is pleased to announce the exclusive patent licensing from the University of Idaho pertaining to a natural biopesticide mustard-based treatment of stored produce and other foods, particularly sprout suppression of potatoes.

Keep reading... Show less